Navigation auf uzh.ch

Suche

UZH Innovation Hub

Newsroom

News list

  • UZH Spin-off has won the leading Swiss startup competition 2024

    Kevin Yim wins with EVIIVE the first place in Switzerland's leading start-up competition >>venture>>, which recognizes the best business ideas and business plans in Switzerland. 

  • Boosting Talents – Annual Report 2023

    The Innovation Hub's 2023 annual report provides an overview of innovation activities at UZH as well as inspiring stories – take a look.

  • TOP 100 Swiss Startup Award

    The public voting for TOP 100 Swiss Startups is your chance to highlight an excellent Swiss startup. Please vote for entrepreneurs from the University of Zurich!

  • DIZH Innovation program: Funded Projects

    In the 3rd Project Call of the DIZH Innovation Program, 14 projects are being funded, 10 with team members of UZH.

  • Innovators Camp 2024 – successful Social Innovators

    Over 20 participants responded to the call «Are you motivated to make a positive social impact?» and worked in interdisciplinary groups to develop digital solutions to current issues.

  • Core Technologies for Healthy Longevity Innovation

    The 4th UZH Healthy Longevity Innovation Days will focus on «Core Technologies for Healthy Longevity Innovation».

  • Innovator Mornings – Exchange among innovators

    Interview with Josua Jordi, CEO and co-founder of EraCal at the Innovator Mornings

  • Successful start: Innovators Camp 2024

  • Biotech company opts for UZH spin-off Oncobit

    Oncobit, founded in 2018 as a UZH spin-off, announces partnership with Immunocore to advance therapy response analysis in clinical trials.

  • FimmCyte funded by the UZH Life Science Fund

    The UZH Life Science Fund awards CHF 1 million for FimmCyte.

  • Falling Walls Lab 2019

    Falling Walls Lab Switzerland

    Which wall will your research break? Pitch your innovative idea in just 3 minutes, showcasing a breakthrough that creates a positive impact on science and society. For Students and early career researchers of all disciplines.

  • Emilia Pasquier, Darren Cooke and Eva Maria Håkanson

    Nextcasts – From lab to market: Unlocking Innovation at Universities

    The Deputy Head Innovation Office at the University of Zurich, Eva Maria Håkanson talks on the Swissnex San Francisco Podcast about moving ideas from the university to market.

  • Sustainable Digital Finance - CALL #1

    The Innovation Booster “Sustainable Digital Finance” aims to accelerate radical innovations that foster sustainability in the financial industry by harnessing technology. The University of Zürich is the leading house for this InnoBooster.

  • Sparkling Research: Honoring UZH Entrepreneur Fellows

    The Vice-Rector for Research, Prof. Elisabeth Stark awarded certificates to Simon Bredl, Simon Gruening and Kevin Yim for their successful completion of the UZH Entrepreneur Fellowship program in 2023.

  • UZH spin-off new partnering deal

    Congratulations to UZH spin-off EraCal Therapeutics to their new partnering deal with Novo Nordisk. This is a huge step foward for the start-up, with a potential value of EUR 235 million, and brings revolutionary therapy for obesity one step closer to the market.

  • Projects supported by the DIZH Founder Call

    The 1st Founder Call by DIZH enables projects from the idea to the proof of concept that aim to establish a start-up or spin-off. Ten projects were recently approved: Get an insight into the six convincing projects by UZH Researchers.

  • UZH Innovathon: Winners

    The hands-on innovation course format offers a unique opportunity to enhance students personal and professional growth. One team impressed the jury with the most developed solution towards the challenge proposed and won not only the jury prize for the best concept but also the audience prize.

  • Spin-off for immunotherapy

    UZH researchers have co-founded Seito Biologics AG to develop a new treatment for autoimmunty. After several years of research at the Department of Immunology of the University of Zurich, the team is now ready to take the next step with their approach, which is based on selective Treg cell engagers (TREX).

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    Celebrating Research

    UZH researchers are invited honoring excellent research ventures and celebrating their successes.

  • Receiving Innosuisse Funding

    How do I set up an innovation project and get funding from Innosuisse? Advice from experts at a recent event. 

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    Hans Eggenberger Foundation extends support for the UZH Entrepreneur Fellowship Program

    The Hans Eggenberger Foundation has extended its financial support for the UZH Entrepreneur Fellowship Program for another three years.

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    UZH at the Switzerland-Japan Economic Forum

    Government, academic and business leaders from Japan and Switzerland gathered at the Switzerland-Japan Economic Forum 2023 in Tokyo to explore the critical role of innovation promotion. UZH Vice President Christian Schwarzenegger shared his expertise on the Swiss ecosystem and the UZH Innovation Hub, a platform for innovation and entrepreneurship at Switzerland’s largest university

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    Enzian Pharmaceutics and UZH develop a novel gastroretentive fibrous dosage form

    In a collaborative project funded by Innosuisse and Enzian Pharmaceutics, scientists at Enzian Pharmaceutics and the University of Zurich (UZH) have reached an important milestone in the development of a new gastroretentive dosage form.

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    Arcton raises 350k CHF in the pre-seed round

    Arcton, a UZH startup and Zurich-based fintech startup founded in 2022, disrupts the Swiss crowdfunding scene with its innovative investing platform. Crowd investing in Switzerland has experienced a significant surge in popularity, with platforms primarily focused on capital raising.

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    INNOVATOR MORNINGS - Successful launch of a new event series

    As part of the UZH Entrepreneur Fellowships and the UZH Innovation Grants programs, the UZH Innovation Office has launched a brand new event series "Innovator Mornings".

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    metaLead wins final stage of Venture Kick

    Venture Kick awarded CHF 150’000 to metaLead, a BioTech UZH Spinoff project, which is developing next-gen antidotes against toxic metals. 

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    E.rupt selected in Future of Health Grant program

    CSS and EPFL Innovation Park announced last week the innovation projects that have been selected in their Future of Health (FoHG) program. 

  • UZH Biomedicine Professor Magdalini Polymenidou becomes Global Scholar

    The Novartis Institutes for BioMedical Research (NIBR) is seeking to advance science through the NIBR Global Scholars Program (NGSP). This competitive program supports projects focused on novel science with the objective of being translated to drug discovery and/or clinical research. Magdalini Polymenidou has been selected for the NGSP 2022 and will receive up to 1 mil USD funding over three years along with scientific expertise from NIBR collaborators.

  • News

    Prometheus AG wins Orbital Reef Starter Innovation Challenge

    Prometheus AG wins the Orbital Reef Starter Innovation Challenge.

  • News

    Prometheus and askEarth join ESA BIC Switzerland

    Two new UZH spin-offs join ESA BIC Switzerland, the Swiss Space Incubator 

  • eracal news

    EraCal Therapeutics collaborates with Nestlé Health Science

    Research collaboration between EraCal Therapeutics and Nestlé Health Science

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    SignMax is the winner of the Bootcamp 2022

    SignMax is the winner of the Digital Entrepreneurship Bootcamp 2022 edition. 

  • aiEndoscopic at SIC

    aiEndoscopic wins Swiss Innovation Challenge

    Former  UZH MedTech Entrepreneur fellow David Gage and aiEndoscopic won  the Swiss Innovation Challenge 2022.

  • aiEndoscopic at SIC

    PayMate is the winner team of the UZH Innovathon

    PayMate is the winner team  of the UZH Innovathon: Building a human-centered Future of Work.

  • Cofounder Francesco Baviano

    Arcton pitch at Start-up Nights

    UZH Entrepreneur Fellow Merens Derungs and his startup Arcton were among the illustrious circle of 6 startups that were allowed to present themselves at the Startup Nights in Winterthur.  

  • Navignostics

    Navignostics raises CHF 7.5M in seed financing round

    The UZH spin-off Navignostics raises CHF 7.5M in a seed financing round to advance precision cancer medicine through spatial single-cell proteomics.

  • Deana Mohr

    MUVON Therapeutics: Phase II clinical trial started

    Former MedTech UZH Entrepreneur fellow Dr. Deana Mohr  and her company Muvon Therapeutics announce first patient enrolled in phase II clinical study.

  • We are hiring Innovation Coordinator 50%

    We are hiring: Innovation Coordinator 50%

    Im UZH Innovation Office übernimmst Du administrative und operative Aufgaben zur Unterstützung der verschiedener Aktivitäten im UZH Innovation Hub. Es wartet eine vielseitige und verantwortungsvolle Einstiegsposition in einem dynamischen Umfeld auf Dich.

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    Clemedi releases Tuberculini

    Former MedTech UZH Entrepreneur fellow Dr. Prajwal and his company Clemedi release Tuberculini, a molecular test for drug-resistant tuberculosis.

  • Ana Montalban

    UZH spin-off Recolony idolized in 20 minutes

    Molecular biologist and former UZH Entrepreneur Fellow Ana Montalban-Arques has made a discovery that could cure colon cancer.

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    InCephalo AG receives EIT Health Gold Track grant

    InCephalo AG receives EIT Health Gold Track grant

  • CS Unternehmerkongress

    Entrepreneurial researchers at the Credit Suisse Entrepreneurs' Conference

    "Engineer the future as an entrepreneur? Why not?" - that was the theme of this year's Credit Suisse Entrepreneurs' Conference. The inspiring panel discussions and keynote speeches also featured entrepreneurial researchers from the University of Zurich.

  • Talent Kick

    Partnering to foster the entrepreneurial journey

    The UZH Innovation Hub is partnering with Talent Kick, a program where students have the opportunity to form interdisciplinary cross-university co-founder teams and benefit from hands-on entrepreneurial experience during studies.

  • Breaking communication barriers

    Breaking communication barriers for better social inclusion

    The University of Zurich with Dr. Sarah Ebling in the lead, has been granted funding for a large innovation project to break communication barriers for better social inclusion. The Swiss Innovation Agency (Innosuisse) has granted CHF 12.4 Mio for this four-year flagship project entitled “Inclusive Information and Communication Technologies” (IICT).

  • Neurimmune

    Approval for new alzheimer’s drug developed at UZH

    The active ingredient aducanumab, which was discovered at the University of Zurich, has been approved for use in the United States as a treatment for Alzheimer’s disease. Aducanumab, a human antibody, is the first treatment to slow down incurable Alzheimer's disease. 

  • Innovators Camp 2021

    Driving innovation for impact together!

    In a facilitated five day innovation sprint students and researchers from three universities will work together to develop, prototype and test new ideas with a  focus on sustainability and impact based on the SDGs.

  • Molecular Partners teams with Novartis

    Molecular Partners teams up with Novartis to develop COVID-19 therapies

    Molecular Partners announced their collaboration with Novartis on potential medicines for use against COVID-19. Molecular Partners will be responsible for Phase 1 and 2 trials for its two therapeutic candidates. If the trials are successful, Novartis will be responsible for further development, manufacturing, and global commercialization.

  • Molecular Partners teams with Novartis

    Biotech spin-offs University of Zurich

    The majority of the spin-offs founded at the UZH are active in the fields of biotech and medicine. At the UZH Innovation Hub we support research projects in four innovation areas, including biotech and life sciences. 

  • RISE competition

    Join the U21 RISE Competition - Submit your environmental and/or societal development project until 18th November 2020!

    Do you have a voluntary, social enterprise or environmental project that you would like to scale up, develop, and build? Are you looking for additional support and resources to grow your reach? Then U21 RISE is for you.

  • Digital Entrepreneurship Bootcamp

    Shape the future of digital transformation - Apply for the Digital Entrepreneurship Bootcamp until 9 October 2020!

    Kick off your digital business idea with the help of experienced tech founders and experts. Apply now for the Digital Entrepreneurship: Bootcamp!

  • Bilateral Award

    Italian Bilateral Scientific Cooperation Award: Apply until 31 August 2020

    Find and meet the perfect match thanks to the Futurepreneuship’s “Young professional program” !

  • EraCal News

    EraCal nominated for The Spinoff Prize

    EraCal Therapeutics, a spin-off from the University of Zurich and Harvard University, developed a new drug candidate for obesity and is now a finalist for The Spinoff Prize.

  • Dave Gage News

    Pitch prize for intubation aid - Entrepreneur Fellow Dave Gage in interview

    Dave Gage and his team won the final pitch in the Innosuisse Business Concept Course. With aiEndoscopic they are developing an intubation aid for emergency physicians and anesthetists.

  • Blutgeäße

    Increased Usability and Precision in Vascular Imaging

    Researchers at the University of Zurich have developed a new X-ray contrast agent. The contrast agent is easier to use and distributes into all blood vessels more reliably, increasing the precision of vascular imaging. This reduces the number of animals required in research experiments.

  • VentureLeadersLifeSciences

    Venture Leaders Life Sciences program

    Two UZH startups have been selected for this year’s Venture Leaders Life Sciences program.

  • Yannick Devaud at the UZH Life Science Incubator Lab in Schlieren, near Zurich, where the biotechnologist is free to use the research equipment to prepare and perfect his invention for market.

    Entrepreneur in the incubator

    Translating findings from medical research into applications to help people — that is the overriding aim of the MedTechEntrepreneur Fellowships at the University of Zurich, which are funded by the Werner Siemens Foundation.

  • Refining Breast Cancer Classification

    Refining Breast Cancer Classification by Multiplexed Imaging

    An imaging approach developed at UZH enables the study of breast cancer tissue in greater detail.

  • wingman ventures

    $60 Million for Swiss Startups - Successful Founders to Launch Venture Fund

    Wingman Ventures is ready to make a mark. The independent venture fund is all about providing know-how and financial support to help Swiss startups become international  market leaders. The fund is investing USD 60m in Swiss tech startups exclusively. 

  • Section of a mammary gland generated by dental epithelial stem cells

    Milk from Teeth: Dental Stem Cells Can Generate Milk-Producing Cells

    According to a new study from researchers at the University of Zurich, dental epithelial stem cells from mice can generate mammary ducts and even milk-producing cells when transplanted into mammary glands.

  • Picture Bacteria Strands

    Antibiotics with Novel Mechanism of Action Discovered

    Swiss researchers co-headed by the University of Zurich have now discovered a new class of antibiotics with a unique spectrum of activity and mechanism of action.

  • OxyPrem 1.4 sensor

    UZH Spin-off OxyPrem put their innovative oxygen sensors in use in neonatal clinics around the world

    The OxyPrem team, headed by UZH Entrepreneur Fellow Alumnus Stefan Kleiser, are on a high. Only a few days ago their device OxyPrem 1.4 was granted the CE mark.

  • Digital Day 2018

    How Digitalization Changes Medicine

    On Digital Day, UZH presents ways in which digital technology can change and advance medicine.

  • future.preneurship

    The World of Future.preneurship

    The Future.preneurship-program is an official spin-off of Impact Hub Zürich, the hot spot for innovation and startups in Switzerland with a community of over 1’500 entrepreneurs. Future.preneurship connects career starters with innovative companies for internships. 

  • Region Zürich Innovationsmeister

    Economic Region of Zurich is European Champion in Innovation

    Zurich is the most innovative region in Europe according to the 9th Regionale Innovationsanzeiger (RIS) of the European Commission.

  • Venture Finalists 2019

    EraCal Therapeutics and Legartis in Top 30 >>venture>> Finalists

    The top 30 finalists of the >>venture>> competition in the categories Hardware, Health & Nutrition, and Software & Services have been announced. Congratulations EraCal Therapeutics and Legartis for joining the finalists!

  • Swiss flag and Matterhorn

    Switzerland tops European Biotech Start-Up Ranking

    Switzerland is the European leader with its strong biotech start-up ecosystem. According to "nature biotechnology", Switzerland ranks first place in scientific output, patenting activity, and venture capital availability.

  • HOOKIPA Logo

    HOOKIPA Pharma Announces Pricing of Initial Public Offering

    Hookipa Pharma, a University of Zurich (UZH) spin-off company, made its initial public offering (IPO) at Nasdaq in New York.

  • LERU

    Student entrepreneurship at research-intensive universities. From a peripheral activity towards a new mainstream

    The paper focuses on the role of research-intensive universities in stimulating and supporting initiatives and programmes related to student entrepreneurship, but also on their role as drivers of entrepreneurial ecosystems.  

  • Yannick Devaud Team

    Yannick Devaud won 10'000 CHF from Venture Kick

    Yannick Devaud, a Post-doctoral fellow at the University Hospital Zurich, is one of the four winners of Venture Kick Winners Nationwide.

  • Logo Anaveon AG

    UZH spin-off Anaveon successfully closed a CHF 35 million Series A financing

    UZH spin-off Anaveon successfully closed a CHF 35 million Series A financing with the lead investor Syncona Ltd. based in the a UK.

  • test

    UZH Innovation Hub is live!

    Learn more about the UZH Innovation Hub on the new UZH website regarding innovation, entrepreneurship and venture creation.

  • test

    Winner Social Entrepreneurship Seminar 2018

    On Friday, Dec-7, the 2018 edition of the UZH Social Entrepreneurship seminar came to an end. This year, students were pitching social business ideas to either decrease plastic waste or to improve basic opportunities to children of migrant families.

Weiterführende Informationen

News UZH

News Unitectra

News UZH Foundation